Rankings
▼
Calendar
BDSX Q4 2019 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$138M
Q4 2019 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$8M
Gross Profit
$6M
77.9% margin
Operating Income
-$4M
-42.8% margin
Net Income
-$7M
-78.9% margin
EPS (Diluted)
$0.00
QoQ Revenue Growth
+109.8%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$45,000
Balance Sheet
Total Assets
$45M
Total Liabilities
$270M
Stockholders' Equity
-$225M
Cash & Equivalents
$5M
← FY 2019
All Quarters
Q1 2020 →